160 Health International (FRA:O66) Other Stockholders Equity: €41.55 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:O66 160 Health International Ltd FRA:O66
8 GF Score
Price €1.06
! 5 Warning Signs
View Full Analysis

What is 160 Health International Other Stockholders Equity?

160 Health International FRA:O66 -5.84% 8 Other Stockholders Equity is €41.55 Mil as of Dec. 2025. GuruFocus rates FRA:O66 with a GF Score™ of 8/100. The stock has 5 warning signs investors should review.

160 Health International's Other Stockholders Equity for the quarter that ended in Dec. 2025 was €41.55 Mil.

160 Health International's quarterly Other Stockholders Equity declined from Dec. 2024 (€37.46 Mil) to Jun. 2025 (€35.47 Mil) but then increased from Jun. 2025 (€35.47 Mil) to Dec. 2025 (€41.55 Mil).

160 Health International's annual Other Stockholders Equity increased from Dec. 2023 (€28.93 Mil) to Dec. 2024 (€37.46 Mil) and increased from Dec. 2024 (€37.46 Mil) to Dec. 2025 (€41.55 Mil).

160 Health International Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for 160 Health International's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

160 Health International Other Stockholders Equity Chart

160 Health International Annual Data
Trend Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
23.87 28.93 37.46 41.55

160 Health International Semi-Annual Data
Dec22 Dec23 Jun24 Dec24 Jun25 Dec25
Other Stockholders Equity Get a 7-Day Free Trial 28.93 0.00 37.46 35.47 41.55
FRA:O66
8GF Score
160 Health International Ltd FRA:O66
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

160 Health International Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €41.55 Mil mean?
160 Health International (FRA:O66) has a Other Stockholders Equity of €41.55 Mil as of Dec. 2025. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on 160 Health International and its competitors.
Is 160 Health International's Other Stockholders Equity too high?
160 Health International's current Other Stockholders Equity is €41.55 Mil. Overall, 160 Health International has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does 160 Health International's Other Stockholders Equity compare to MCK and COR?
160 Health International's Other Stockholders Equity of €41.55 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Distribution company?
A good Other Stockholders Equity depends on the Medical Distribution industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on 160 Health International and its competitors. 160 Health International's current Other Stockholders Equity is €41.55 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 160 Health International stock overvalued right now?
160 Health International (FRA:O66) has a current Other Stockholders Equity of €41.55 Mil. The current Other Stockholders Equity is €41.55 Mil. 160 Health International's overall GF Score™ is 8/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For 160 Health International (FRA:O66), the current Other Stockholders Equity is €41.55 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

160 Health International Business Description

Other Exchanges 02656:Hong Kong
Address 4078 Dongbin Road, Nanshan Street, 9th, 11th - 12th Floor, Building 2, Yongxin Times Square, Nanshan District, Shenzhen, CHN, 518052
160 Health International Ltd is an experienced pharmaceutical and healthcare product wholesaler and a digital healthcare integrated service provider in China. The company offers a wide assortment of high-quality pharmaceutical and healthcare products under both wholesale and retail models, to address a spectrum of customer needs. In addition, through its online healthcare and wellness service platform, Healthcare 160 Platform. It also provide digital healthcare and wellness solutions, empowering each Platform Participants, including business customers, medical and healthcare institutions, medical professionals, individual users, and third-party merchants, throughout the healthcare value chain and driving the digital transformation of China's healthcare and wellness industry.
8GF Score

Get the complete analysis for FRA:O66

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.06
Price